Open AccessScreening for Mupirocin Resistance in Staphylococcus
Author(s) -
Avr Jeya Sanju,
Sridharan Sathyamoorthy Kopula,
Kennedy Kumar Palraj
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/15230.6678
Subject(s) - mupirocin , staphylococcus aureus , microbiology and biotechnology , cefoxitin , medicine , staphylococcus , minimum inhibitory concentration , staphylococcus haemolyticus , antibiotics , agar diffusion test , antibiotic resistance , methicillin resistant staphylococcus aureus , biology , bacteria , genetics
Mupirocin is widely used topical antibiotic for the treatment of skin and soft tissue infections caused by Staphylococcus and Streptococcus. In addition nasal formulations are approved for the use in nasal eradication of methicillin-resistant Staphylococcus aureus in patients and health care workers. Wide usage of mupirocin has resulted in resistance leading to treatment failure.